Recruiting

Green Light Therapy

Sponsor:

Efforia, Inc

Code:

NCT07282275

Conditions

Body Composition

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

EmeraldLED

Study Details

Brief summary:

Already using Green Light Therapy? Explore how continued use with twice-weekly 20-minute sessions may continue to support positive changes in body composition. Discover whether this non-invasive wellness approach gets better over time to help support energy, balance, and renewal.

Conditions

Body Composition

Study ID

NCT07282275

Start date

Oct 21, 2025

Status verified date

Dec, 2025

Completion date

Oct 21, 2026

Anticipated

Primary completion date

Oct 21, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Can read and understand English.
  • US resident.
  • Willing and able to follow the requirements of the protocol.

Exclusion Criteria:

  • Individuals with eye conditions
  • Individuals not active with Green Light Therapy

Study Design

Enrollment

100 participants

Anticipated

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Single arm where participants act as their own control

Single Arm observational where participants act as their own control

Interventions

EmeraldLED

This device is a customizable, multi-wavelength therapeutic system designed for individualized cosmetic treatments. It features an easy-to-use interface with preprogrammed treatment categories, a wide pulsing frequency range from 1 to 15,000 Hz, and independent wavelength control for precise protocol tailoring. The system delivers five wavelengths-450 nm, 525 nm, 650 nm, 810 nm, and 980 nm-with an output power of 3,325 W and irradiance up to 119 mW/cm².

The green light therapy provided in this study is set at 525 nm.

Primary outcome measure

  • Body Composition Measurement Form [ Time Frame: Change from baseline (Day 1-3) in body composition at 4 weeks after the start of the intervention (Day 27-33). ]
  • Quality of Life and Health Survey [ Time Frame: Change from baseline (Day 1-3) in quality of life and health at 4 weeks after the start of the intervention (Day 27-33). ]
  • Body Image and Self-Perception Survey [ Time Frame: Change from baseline (Day 1-3) in body image and self-perception at 4 weeks after the start of the intervention (Day 27-33). ]

Central Contacts and Locations

Central contacts

Matthew Amsden

646-679-2479help@efforia.com

Locations

Efforia

Recruiting

New York, New York, United States, 10003

Contacts

Matthew Amsden

(646) 679-2479help@efforia.com

More Information

Sponsor

Efforia, Inc

Last update posted

Dec 23, 2025

Last verified

Dec, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Efforia, Inc on 2025-12-23.